• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

    5/16/25 4:10:00 PM ET
    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance
    Get the next $HSIC alert in real time by email

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.

    In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Health Care industry team in the Americas, who became a member of Henry Schein's Board of Directors on May 2, 2025.

    Max Lin leads the Health Care industry team within KKR, and since joining in 2005, he has overseen a number of investments in the areas of dental services and other health care providers, medical products and equipment, and health care software and information technology. Dan Daniel has over three decades of global leadership experience in industrial and health care sectors, including 14 years as Executive Vice President at Danaher, where he oversaw multiple segments and played a key role in advancing the company's culture and business system. In connection with each of their appointments, Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair; Mr. Daniel was appointed to the Compensation Committee; and each of Mr. Lin and Mr. Daniel was appointed to the Strategic Advisory Committee.

    "We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders."

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

    About KKR

    KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250516439220/en/

    Investors

    Ronald N. South

    Senior Vice President and Chief Financial Officer

    [email protected]

    (631) 843-5500



    Graham Stanley

    Vice President, Investor Relations and Strategic Financial Project Officer

    [email protected]

    (631) 843-5500



    Media

    Henry Schein

    Tim Vassilakos

    Executive Director, Global Corporate Communications

    [email protected]

    (516) 510-0926



    KKR

    Liidia Liuksila

    [email protected]

    Get the next $HSIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HSIC
    $KKR

    CompanyDatePrice TargetRatingAnalyst
    KKR & Co. Inc.
    $KKR
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    KKR & Co. Inc.
    $KKR
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    3/20/2025$150.00 → $141.00Equal Weight → Overweight
    Wells Fargo
    Henry Schein Inc.
    $HSIC
    2/14/2025$80.00Equal Weight
    Wells Fargo
    KKR & Co. Inc.
    $KKR
    1/30/2025$173.00Buy → Hold
    HSBC Securities
    Henry Schein Inc.
    $HSIC
    1/6/2025$69.00 → $84.00Underperform → Buy
    BofA Securities
    Henry Schein Inc.
    $HSIC
    12/4/2024$75.00Neutral
    Mizuho
    KKR & Co. Inc.
    $KKR
    9/18/2024$148.00Buy
    HSBC Securities
    More analyst ratings

    $HSIC
    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Kkr Hawaii Aggregator L.P. claimed ownership of 15,652,032 shares (SEC Form 3)

      3 - HENRY SCHEIN INC (0001000228) (Issuer)

      5/16/25 8:48:25 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • New insider Mh Sub I, Llc claimed ownership of 15,652,032 shares (SEC Form 3)

      3 - HENRY SCHEIN INC (0001000228) (Issuer)

      5/16/25 8:43:46 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • New insider Kkr Group Partnership L.P. claimed ownership of 15,652,032 shares (SEC Form 3)

      3 - KKR & Co. Inc. (0001404912) (Reporting)

      5/16/25 8:38:46 PM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Henry Schein Inc.

      DEFA14A - HENRY SCHEIN INC (0001000228) (Filer)

      5/16/25 4:10:22 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

      8-K - HENRY SCHEIN INC (0001000228) (Filer)

      5/16/25 4:07:05 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by KKR & Co. Inc.

      10-Q - KKR & Co. Inc. (0001404912) (Filer)

      5/9/25 4:07:40 PM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

      SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

      11/13/24 3:30:01 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

      SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

      11/12/24 3:50:17 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form SC 13G filed by Henry Schein Inc.

      SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

      11/12/24 9:32:27 AM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    $KKR
    Leadership Updates

    Live Leadership Updates

    See more
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance
    • KKR Appoints Timothy R. Barakett to Board

      KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket

      3/13/25 4:30:00 PM ET
      $KKR
      Investment Managers
      Finance
    • PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

      Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

      3/11/25 7:05:00 AM ET
      $BAX
      $BMRN
      $EMBC
      $HSIC
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Medical Specialities

    $HSIC
    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance
    • Henry Schein to Participate in Upcoming Investor Conference in June

      Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, 2025, at 1:20 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and techno

      5/15/25 6:30:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • KKR to Present at the Bernstein 41st Annual Strategic Decisions Conference 2025

      KKR & Co. Inc. (NYSE:KKR) announced today that Scott C. Nuttall, Co-Chief Executive Officer, will present at the Bernstein 41st Annual Strategic Decisions Conference 2025 on Wednesday, May 28, 2025 at 1:30 PM ET. A live webcast of the presentation will be available on the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. For those unable to listen to the live webcast, a replay will be available on the website shortly after the event. Any questions regarding the webcast may be addressed to KKR's Investor Relations team at [email protected]. ABOUT KKR KKR is a leading global investment firm that offers alternative asset management as well as ca

      5/14/25 4:15:00 PM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Financials

    Live finance-specific insights

    See more
    • FS KKR Capital Corp. Announces First Quarter 2025 Results

      Declares Second Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, May 7, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended March 31, 2025, and that its board of directors has declared a second quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended March 31, 2025(1) Net investment income of $0.67 per share, compared to $0.61 per share for the quarter ended December 31, 2024Adjusted net investment income(2) of $0.65 p

      5/7/25 4:15:00 PM ET
      $FSK
      $KKR
      Investment Managers
      Finance
    • Henry Schein Reports First Quarter 2025 Financial Results

      First-quarter 2025 GAAP diluted EPS of $0.88, growth of 22% compared to the first quarter of 2024 First-quarter 2025 non-GAAP diluted EPS of $1.15, growth of 4.5% compared to the first quarter of 2024 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4% Repurchased $161 million of common stock, or approximately 2.3 million shares Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 29, 2025. "We are pleased with our first quarter financial re

      5/5/25 6:00:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • KKR & Co. Inc. Reports First Quarter 2025 Results

      KKR & Co. Inc. (NYSE:KKR) today reported its first quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501072305/en/ A conference call to discuss KKR's financial results will be held today, Thursday, May 1, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center se

      5/1/25 6:50:00 AM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KKR upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded KKR from Equal-Weight to Overweight and set a new price target of $150.00

      5/14/25 8:50:33 AM ET
      $KKR
      Investment Managers
      Finance
    • KKR upgraded by HSBC Securities with a new price target

      HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $119.00

      4/15/25 8:56:40 AM ET
      $KKR
      Investment Managers
      Finance
    • KKR upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded KKR from Equal Weight to Overweight and set a new price target of $141.00 from $150.00 previously

      3/20/25 7:46:40 AM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Issuer)

      5/8/25 7:01:53 PM ET
      $KKR
      Investment Managers
      Finance
    • Kkr Alternative Assets Llc bought $50,000,000 worth of Class I Common Stock (1,956,182 units at $25.56) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/6/24 9:02:29 PM ET
      $KKR
      Investment Managers
      Finance
    • Kkr Alternative Assets Llc bought $14,285,714 worth of Common Shares of Ben. Interest (571,429 units at $25.00) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      3/28/24 4:33:17 PM ET
      $KKR
      Investment Managers
      Finance